NASDAQ:ONCY - Oncolytics Biotech Inc.
$2.01
 $0.01
+0.50%
2:10PM EDT
2019-02-15
Oncolytics Biotech Inc., incorporated on April 2, 1998, is a development-stage company. The Company is focused on the development of REOLYSIN, its cancer therapeutic. The Company's clinical program is made up of a registration program that includes muscle-invasive bladder cancer and glioma cancer, over six randomized Phase II clinical trials and approximately six other investigative clinical trials. The Company focuses on the registration of REOLYSIN in approximately two indications, including the neoadjuvant treatment of muscle-invasive bladder cancer and the treatment of glioblastoma.The Company has conducted a single arm United States Phase II non-small cell lung cancer (NSCLC) trial and a single arm United States Phase II pancreatic cancer trial for REOLYSIN. The Company is also engaged in conducting a Phase Ib trial for REOLYSIN and chemotherapy in combination with pembrolizumab in its Checkpoint Inhibitor Program. The Company is also involved in a Phase Ib study of REOLYSIN combined with standard doses of bortezomib (VELCADE) and dexamethasone in patients with relapsed or refractory multiple myeloma.. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ONCY     avg for
industry  
  avg for
sector  
42 stocks weight:  16. 31   0. 00   0. 00  
42 stocks rank:  3. 77 K 1. 86 K 1. 09 K

quick ratio:  5. 02   5. 37   1. 81  
current ratio:  5. 46   5. 69   2. 19  

1-yr high:  7. 83   124. 30   142. 77  
last close:  2. 20   101. 85   127. 84  
50-day avg:  2. 06   98. 27   122. 46  
200-day avg:  3. 98   99. 72   122. 70  
1-yr low:  1. 72   78. 19   100. 16  
volume:  38. 14 K 2. 38 M 4. 64 M
50-day avg volume:  74. 72 K 3. 31 M 4. 94 M
200-day avg volume:  65. 77 K 3. 23 M 4. 28 M

1-day return:  -2. 44 % 0. 22 % 0. 48 %
this week return:  -8. 26 % 1. 77 % 2. 01 %
12-wk return:  -13. 79 % 6. 56 % 3. 33 %
52-wk return:  -54. 59 % -2. 23 % 14. 35 %

enterprise value (EV):  37. 19 M 55. 17 B 104. 51 B
market cap:  33. 95 M 49. 01 B 96. 46 B

shares outstanding:  17. 06 M 607. 99 M 1. 22 B
shares:  16. 98 M 605. 53 M 1. 15 B
shares short:  91. 36 K 11. 62 M 12. 55 M
shares short prior month:  83. 66 K 11. 95 M 13. 44 M
short ratio:  1. 01   4. 82   3. 10  
short % of float:  0. 61 % 6. 19 % 2. 82 %

book value:  0. 40   14. 43   28. 26  
price/book:  4. 98   -1. 57   -2. 97  
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  0. 00 % 13. 81 % 22. 47 %
profit margins:  0. 00 % 6. 57 % 9. 92 %
gross margins:  0. 00 % 49. 33 % 54. 53 %

1-yr max volatility:  -19. 21 % --- ---
1-yr mean volatility:  -0. 23 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 82   3. 03   4. 09  
P/E:  -2. 42   6. 11   26. 91  
PE/G:  0. 08   0. 37   5. 61  
growth:  -29. 20 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -59. 24 % -3. 27 % 3. 81 %
return on equity:  -160. 67 % 107. 48 % 27. 82 %

beta (1yr vs S&P500):  1. 12   1. 21   0. 93  
sharpe (1yr):  -0. 75   0. 06   0. 98  


Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : ONCY
.    + 0.589 =         0.589 :: INITIAL WEIGHT
.  + 256.729 =       257.318 :: inverse volume-to-price addition
.  + 265.787 =       523.105 :: spline projection addition
.  - 192.366 =       330.738 :: poor performance penalty
.    x 0.642 =       212.397 :: one-year gains+dividend factor
.    x 4.612 =       979.557 :: 13 weeks' performance factor
.    x 1.492 =      1461.978 :: industry recommendation factor
.    x 0.994 =      1453.318 :: return on assets factor
.    x 0.984 =      1429.967 :: return on equity factor
.     x 2.96 =      4232.244 :: current ratio factor
.    x 1.118 =       4729.79 :: quick ratio factor
.    x 1.411 =      6672.356 :: short ratio factor
.     x 2.05 =      13676.67 :: price-to-book factor
.    x 1.008 =     13782.691 :: 5-day avg > 50-day avg
.    x 2.162 =      29794.01 :: P/E weight
.    x 1.863 =     55506.825 :: PE/G factor
.    x 1.619 =     89842.961 :: beta factor
.    x 0.748 =       67231.3 :: sharpe factor
.    x 1.066 =     71642.534 :: industry 12-weeks return
.    x 0.924 =     66179.172 :: "drift" penalty 3 days ago
.    x 0.996 =     65882.417 :: overall "drift" factor
.    x 0.999 =     65825.931 :: largest single-day jump factor
.    x 0.066 =      4336.359 :: low price factor
.      x 1.0 =       4336.65 :: factor hist industry gain for week 06
.   cubeRoot =        16.307 :: reduced for readability
.                     16.307 :: FINAL WEIGHT for NASDAQ:ONCY


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org